drugset / Trial / NCT00470925
Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
Phase 1
Terminated
30 enrolled
Institute for Neurodegenerative Disorders
Molecular NeuroImaging · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The overall purpose of this project is to evaluate the effect of sertraline administration on the binding of 123-I mZINT in 10 healthy subjects. All study procedures will be conducted at the Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging (MNI) in New Haven, CT.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-02
- Completion
- 2008-02
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | 123-I MZINT | Unknown | — | — |